SITC Cancer Immunotherapy CONNECT

Learn more about the new SITC Biotech Initiative

Browse our other events


Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Explore the 2024 ACI Series
SITC Deep Dive

Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines

Live Webinar 3: Tuesday, July 9, 2024, from 12–2 p.m. EDT

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.

Register Today
Glyco-Immunology Webinar

2024 Glyco-Immunology Webinar Series

Presented by SITC and the Society for Glycobiology, this FREE webinar series will address the impact of glycobiology on immune regulation, anti-tumor immunity, and immune resistance. Develop more effective cancer immunotherapies by applying principles of glyco-immunology.

EXPLORE SERIES
SITC Deep Dive

A Global Webinar Series - Cell Therapy Administration: Increasing Access to IO

Live Webinar 2: Wednesday, July 10, 2024 - 8:30–10 a.m. EDT

These free digital events provide a forum for international physicians to discuss overcoming barriers in administering local immunotherapy treatment.

Register Today

ACI Lung

Advances in Cancer Immunotherapy™: A Focus on Lung Cancers

Tuesday, June 25 |1–5 p.m. ET
Virtual – Zoom

Program features a discussion on immunotherapy and biomarker-driven lung cancer. FREE for healthcare professionals, students, patients and patient advocates.

View Details
SITC Summit on Immunomodulation of Antibody-drug Conjugates

SITC Summit on Immunomodulation of Antibody-drug Conjugates

Wednesday, June 26, 2024 
11 A.M.–3 P.M.

The free summit will highlight the current understanding of antibody-drug conjugates (ADCs) and their effects on the immune system and the tumor microenvironment.

REGISTER TODAY
FAIO

Nominate an Emerging Leader in IO

Submit Nominations by July 15

The Steven A. Rosenberg Scholars Award is one of the society's most prestigious opportunities for early career scientists. If you know a deserving emerging leader, nominate them by July 15, 2024.

LEARN MORE AND NOMINATE
ACI Hematologic

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

Register
SITC Drug Development Summit

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More
ACI Toxicity Management

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Explore Program
2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical ...

 Latest Discussions

  • Hello! Attached is a flyer for the SITC Summit on Intralesional Immunotherapy: ...

  • Hello! Attached is a flyer for the SITC Summit on Immunomodulation ...

  • Hello, It's that time of year when SITC seeks the best and brightest to ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family